VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 71 filers reported holding VBI VACCINES INC in Q1 2020. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $17,663 | -100.0% | 45,163 | -51.0% | 0.00% | – |
| Q3 2022 | $65,012,000 | +68.7% | 92,111 | +93.2% | 0.00% | – |
| Q2 2022 | $38,540,000 | +50.4% | 47,668 | +208.7% | 0.00% | – |
| Q1 2022 | $25,632,000 | -72.0% | 15,441 | -60.6% | 0.00% | – |
| Q4 2021 | $91,667,000 | -11.9% | 39,174 | +17.1% | 0.00% | – |
| Q3 2021 | $104,067,000 | +224.8% | 33,462 | +249.8% | 0.00% | – |
| Q2 2021 | $32,043,000 | -66.3% | 9,565 | -68.7% | 0.00% | – |
| Q1 2021 | $95,175,000 | +49.5% | 30,603 | +32.2% | 0.00% | – |
| Q4 2020 | $63,668,000 | -51.7% | 23,152 | -49.8% | 0.00% | – |
| Q3 2020 | $131,812,000 | +231.9% | 46,088 | +259.7% | 0.00% | – |
| Q2 2020 | $39,717,000 | -11.7% | 12,812 | -72.9% | 0.00% | – |
| Q1 2020 | $44,978,000 | +11.0% | 47,345 | +61.3% | 0.00% | – |
| Q4 2019 | $40,503,000 | +2193.5% | 29,350 | +683.1% | 0.00% | – |
| Q3 2019 | $1,766,000 | +106.3% | 3,748 | +412.0% | 0.00% | – |
| Q2 2019 | $856,000 | -1.2% | 732 | +58.1% | 0.00% | – |
| Q1 2019 | $866,000 | +16.9% | 463 | 0.0% | 0.00% | – |
| Q4 2018 | $741,000 | -19.5% | 463 | +21.8% | 0.00% | – |
| Q3 2018 | $920,000 | -12.0% | 380 | 0.0% | 0.00% | – |
| Q2 2018 | $1,045,000 | -95.6% | 380 | -94.4% | 0.00% | – |
| Q1 2018 | $23,891,000 | -21.4% | 6,826 | -4.1% | 0.00% | – |
| Q4 2017 | $30,402,000 | +273.0% | 7,120 | +236.3% | 0.00% | – |
| Q3 2017 | $8,150,000 | -17.6% | 2,117 | -6.9% | 0.00% | – |
| Q2 2017 | $9,892,000 | – | 2,274 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|